Stay updated on Pembrolizumab and Binimetinib in TNBC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.
Latest updates to the Pembrolizumab and Binimetinib in TNBC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference2%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added a 'Show less' feature, while several detailed data fields and options related to participant groups, interventions, and downloads have been removed.SummaryDifference3%
- Check41 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics, breast cancer, and clinical trials, which may impact access to important medical information.SummaryDifference0.3%
- Check48 days agoChange DetectedThe website has added several new resources related to genetics and clinical trials, including links to MedlinePlus and DailyMed, as well as a new version update to v2.12.2.SummaryDifference3%
- Check55 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab and Binimetinib in TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Binimetinib in TNBC Clinical Trial page.